New Alzheimer's drugs will actually slow the disease

The drugs take aim at the plaque buildups in the brain that characterize Alzheimer's, known as beta amyloid. The medicines are in development at Biogen and Eli Lilly. New data will be presented Wednesday at the Alzheimer's Association International Conference in Washington, D.C.
Read more: CNBC